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We have previously shown that Sox18 is expressed in developing vascular endothelium and hair follicles
during mouse embryogenesis and that point mutations in Sox18 are the underlying cause of cardiovascular and
hair follicle defects in ragged (Ra) mice. Here we describe the analysis of Sox182/2 mice produced by gene
targeting. Despite the profound defects seen in Ra mice, Sox182/2 mice have no obvious cardiovascular defects
and only a mild coat defect with a reduced proportion of zigzag hairs. A reduction in the amount of
pheomelanin pigmentation in hair shafts was also observed; later-forming hair follicles showed a reduced
subapical pheomelanin band, giving Sox182/2 mice a slightly darker appearance than Sox181/1 and Sox181/2
siblings. Sox182/2 mice are viable and fertile and show no difference in the ability to thrive relative to
littermates. Because of the mild effect of the mutation on the phenotype of Sox182/2 mice, we conclude that the
semidominant nature of the Ra mutations is due to a trans-dominant negative effect mediated by the mutant
SOX18 proteins rather than haploinsufficiency as has been observed for other SOX genes. Due to the similarity
of SOX18 to other subgroup F SOX proteins, SOX7 and 217, and the overlap in expression of these genes,
functional redundancy amongst these SOX proteins could also account for the mild phenotype of Sox182/2
mice.
Members of the SOX (Sry-type HMG box) gene family en-
code transcription factors that have a wide range of roles in
development (reviewed by Wegner [39]). SOX proteins bind
DNA in a sequence-specific manner, and a heptameric SOX
consensus binding motif, 59-(A/T)(A/T)CAA(A/T)G-39, has
been identified (12). Most tissues and cell types express at least
one SOX gene at one stage or another of their development
(39). Moreover, many cell types or tissues express more than
one SOX gene at certain times (6, 20, 22, 36, 37).
Gene targeting experiments with the mouse have assigned
vital roles in development to numerous SOX genes: Sox1 in
lens formation (28), Sox4 in cardiac tract outflow formation
and B-lymphocyte development (32), and Sox9 in chondrogen-
esis (3). This has been reinforced by mutations in human SOX
genes: SRY mutations in sex reversal and gonadal dysgenesis
(2, 11, 13, 15), SOX9 mutations in the bone dysmorphogenesis
and sex reversal syndrome campomelic dysplasia (9, 38), and
SOX10 mutations in various neurocristopathies such as Waar-
denberg-Shah syndrome 4 (30) and the Yemenite deaf-blind
hypopigmentation syndrome (4). Further, such mutations have
revealed an importance of dosage for some SOX genes, with
deletion or mutation of one allele of SOX9 or SOX10 resulting
in a disease phenotype (9, 30, 38).
We have previously shown that point mutations in Sox18 are
the underlying cause of profound cardiovascular and hair fol-
licle defects in ragged (Ra) mice (29). Ra heterozygotes have
thin, ragged coats comprised of guard hairs but lacking the
later-forming auchenes and zigzags (5). Ra homozygotes, how-
ever, almost completely lack vibrissae and coat hairs, display
generalized edema and cyanosis, and rarely survive past wean-
ing (5). In a more severe Ra mutation, RaOp, heterozygotes
typically show a phenotype similar to that of Ra homozygotes,
whereas RaOp homozygotes die by 11.5 days postcoitus (dpc)
(10, 24). The coat defects in Ra mice are due to a reduction in
the total number of hair follicles, with the later-forming folli-
cles being the most affected (33).
In Ra mice, the Sox18 mutations lead to an intact DNA-
binding domain but a nonfunctional trans-activation domain
(29). Given the semidominant nature of the Ra mutations (5,
10), it was not clear whether the phenotype of Ra mice was due
to haploinsufficiency of Sox18, as has been described for other
SOX genes, or whether there was a dominant-negative effect of
the mutant SOX18 protein. To address this question, we pro-
duced mice null for Sox18, and we describe here their produc-
tion and analysis.
MATERIALS AND METHODS
Targeting of Sox18 and production of chimeric mice. Overlapping genomic
clones hybridizing to Sox18 were obtained from a l phage library constructed
from 129/Sv genomic DNA which was partially digested with MboI and cloned
into the BamHI sites of lDashII vector (Philippe Soriano, personal communi-
cation). Four overlapping clones were mapped using restriction digests and
Southern hybridization. The 1.8-kb, 59 flanking fragment was generated by high-
fidelity PCR from a genomic clone to incorporate XbaI sites and facilitate
subcloning. The 39 flanking arm was an 11-kb fragment subcloned from a
genomic clone. The 39 and 59 flanking sequences were cloned into a plasmid,
pLoxPneo-1, that contains a neomycin resistance cassette (neor) driven by the
PGK-1 promoter, all flanked by directional LoxP sites (A.N., unpublished data).
The LoxP sites were included to allow the excision of intervening sequence in the
presence of cre recombinase (1). A promoterless lacZ reporter cassette (19) was
subcloned into the targeting vector so that an in-frame SOX18–b-galactosidase
fusion protein would be produced to facilitate gene expression studies. A thy-
midine kinase cassette (25) was used in the targeting vector for counterselection
in embryonic stem (ES) cells.
Gene targeting was performed in the R1 ES cell line (27) using standard
protocols (16), with the exception that ES cells were grown in the absence of
feeder fibroblasts cells on gelatinized plastic tissue culture dishes in media sup-
plemented with leukemia inhibitory factor, and 40 mg of linearized targeting
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vector was used in each electroporation cuvette. G418-resistant ES cell clones
were screened for homologous recombination using genomic Southern blots
after HindIII digestion. An external probe was used to detect a native 12-kb band
or a band of 8.5 kb in targeted alleles. Two independent ES cell clones were
identified as homologous recombinants. Chimeric embryos were produced from
them by using CD1 donor embryos and the technique of morula aggregation (41)
and transferred to pseudopregant recipients as described by Hogan et al. (14).
Germ line transmission of the targeted Sox18 allele was achieved with chimeras
produced from the two independently targeted ES cell lines. Analysis of the
targeted mutation was conducted on mice and embryos of a 129/Sv-CD1 mixed
genetic background.
Genotyping of mice and embryos. Mice and embryos used in this study were
genotyped by genomic DNA Southern hybridization (as described above for
screening ES cell clones) or by PCR on genomic DNA prepared from ear
punches or tail clips as described by Joyner (16). To detect the targeted allele, the
neor-specific primers neoR (59-CAA GCT CTT CAG CAA TAT CAC G-39) and
neoF (59-ATC TCC TGT CAT CTC ACC TTG C-39) were used. To detect the
wild-type Sox18 allele, the primers Sox18-Box A (59-CCA ACG TCT CGC CCA
CCT CG-39) and Sox18-Box B (59-GCC GCT TCT CCG CCG TGT TC-39) were
used. Mutant embryos were always genotyped by PCR amplification from a
portion of the yolk sac or allantois that had been well rinsed in a large volume of
phosphate-buffered saline.
RT-PCR analysis. cDNA was produced in a reaction mixture containing 1 mg
of RNA, 13 “first-strand” buffer (Gibco BRL; 50 mM Tris-HCl [pH 8.3], 75 mM
KCl, 3 mM MgCl2), 375 mM deoxynucleoside triphosphates, 100 mM dithiothre-
itol, 500 ng of pd(N)6 random primers (Pharmacia), 200 U of Moloney murine
leukemia virus reverse transcriptase (RT) (Gibco BRL), and RNase-free MilliQ
water in a total volume of 30 ml. The reaction mixture was incubated at 42°C for
1 h, and 5 ml was used in a 25-ml PCR. The primer pairs used were as follows: for
detection of neor transcripts, neoR (59-CAA GCT CTT CAG CAA TAT CAC
G-39) and neoF (59-ATC TCC TGT CAT CTC ACC TTG C-39); for lacZ
transcripts, LacZ A (59-CAG CAC ATC CCC CTT TCG CC-39) and LacZ B
(59-CCA ACG CAG CAC CAT CAC CG-39); for the 39 portion of Sox18
downstream of the lacZ reporter and neor (encoding the trans-activation do-
main), Sox18-39 A (59-GGC TTT CCG GGC ACC CTA TG-39) and Sox18-39 B
(59-AAG CGG TGG AGG GCA AGG AC-39); for the region of Sox18 encoding
the HMG box, Sox18-Box A (59-CCA ACG TCT CGC CCA CCT CG-39) and
Sox18-Box B (59-GCC GCT TCT CCG CCG TGT TC-39); for the 59 region of
Sox18 upstream of the lacZ reporter and neor, Sox18-59 A (59-TGA GAC AGT
GGG AGC AGA TGG-39) and Sox18-59 B (59-GCA AAG CCA AGT ACG
GAG GTC 39); and for GAPDH transcripts, GAPDH F (59-TCG GTG TGA
ACG GAT TTG-39) and GAPDH R (59-ATT CTC GGC CTT GAC TGT-39).
Expression studies. Whole-mount immunohistochemistry was done using an
anti-PECAM-1 (CD31) antibody (Pharmingen, San Diego, Calif.) at a dilution of
1/250, using standard techniques described elsewhere (40).
Analysis of the coats of Sox182/2 mice. The coat qualities of adult Sox182/2
and control mice were analyzed by visual inspection, and mice were photo-
graphed with standard color-reversal film. To survey the relative abundance of
the various hair types among the coats of Sox182/2 and control mice, hairs were
plucked in bunches from the middorsa of adult mice, typically 3 months of age.
A broad pair of forceps (Millipore) was used to obtain three samples from each
test subject. A dissecting microscope was used to count the hairs of each type
according to the mouse hair classification of Dry (7). The total number of hairs
from each subject varied between 160 and 380 in order to give a statistically valid
sampling of hair types. Photography of mouse hairs was performed on a dissect-
ing stereomicroscope (Leica MZ8) with bright-field illumination after hairs were
dry mounted on a microscope slide with a coverslip and nail polish.
RESULTS
Targeting of the Sox18 gene. The gene targeting strategy was
designed to produce mice null for Sox18 by removing the
region encoding the HMG box (DNA-binding domain) and
replacing it with a lacZ reporter cassette and a neor cassette,
both of which contain transcription termination sequences.
Southern blot analysis of genomic DNA from Sox182/2 and
Sox181/2 mice confirmed that the Sox18 locus had been tar-
geted as expected, with the region encoding the HMG box
being removed and replaced by the lacZ and neor cassettes
(Fig. 1). However, analysis of Sox182/2 and Sox181/2 embryos
at 9.5 dpc, a stage when Sox18 is expressed strongly in the
developing vascular system (29), failed to show b-galactosidase
staining (data not shown). Sequencing of the targeting vector
confirmed that an in-frame fusion protein comprising the N-
terminal 89 amino acids of SOX18 and b-galactosidase (data
not shown) should have been produced. It is unclear why the
lacZ reporter cassette is nonfunctional in Sox182/2 and
Sox181/2 embryos, though one possibility is that the N-termi-
nal 89 amino acids of SOX18 interfered with the enzymatic
activity of b-galactosidase.
RT-PCR analysis of the mutant transcript. To analyse which
transcripts were produced from the targeted Sox18 locus, RT-
PCR was conducted on RNA from mutant and wild-type em-
FIG. 1. Disruption of Sox18 by gene targeting. (a) Structure of Sox18 and
gene targeting by homologous recombination. The targeting vector was designed
to replace the regions of exon 1 and 2 (X1 and X2) encoding the HMG box
domain (hatched boxes) with a lacZ reporter cassette (LacZ) and a neor selection
cassette (neo). The probe was designed for screening for homologous recombi-
nants in ES cells by HindIII digestion of genomic DNA. pA, polyadenylation site;
TK, thymidine kinase cassette; Xb, XbaI restriction site; H, HindIII restriction
site. (b) Detection of homologous recombinants in ES cells. (Left) Southern
blotting of G418-resistant genomic DNA digested with HindIII (using the exter-
nal probe) revealed a wild-type band of approximately 12 kb and a targeted band
of 8.5 kb as expected. (Right) Probing the same Southern blot with an internal
probe (lacZ fragment) revealed a targeted band of 8.5 kb, as expected, indicating
that there was a single homologous recombination event. (c) Genotyping of
Sox182/2 mice by Southern blotting. (Left) The same strategy was used as for
screening ES cells, revealing the genotype of wild-type, heterozygous, and ho-
mozygous knockout mice. (Right) Probing the same Southern blot with a probe
specific to the HMG box-encoding region confirmed that this region was re-
moved in the targeted loci.












bryos. RT-PCR analysis confirmed that there were no tran-
scripts from the HMG box domain-encoding region from the
targeted allele (Fig. 2). As can be seen in Fig. 2, the pattern of
neor and lacZ expression was also as expected, being present
only in embryos carrying a targeted locus. Analysis of the
region encoding the trans-activation domain (downstream of
the lacZ and neor cassettes), however, revealed that this por-
tion of the gene was transcribed from both wild-type and tar-
geted loci. In addition, a portion of the coding region 59 to the
lacZ and neor cassettes, and common to both wild-type and
targeted loci, appeared to be transcribed only from the tar-
geted locus. It is known that this region is transcribed under
normal circumstances and that mRNA secondary structure
does not interfere with reverse transcription in this region,
since this sequence is present in cDNA clones derived by
reverse transcription (8). We are therefore unable to explain
the lack of expression of the 59 region of Sox18 observed in
these experiments.
Sox182/2 mice are viable and fertile. Germ line transmission
of the targeted Sox18 allele was achieved by breeding male
chimeras derived from the two independently targeted ES cell
lines. Genotyping of litters from intercrosses of F1 Sox18
1/2
heterozygotes revealed that Sox182/2 mice appeared in Men-
delian ratios. Breeding studies also indicated that the Sox182/2
mice could interbreed, proving that they were fertile (data not
shown).
Anatomical analysis of Sox182/2 embryos. As Sox182/2
mice appeared to have no reduced viability or fertility, there
were likely to be no major cardiovascular defects associated
with the targeted mutation. Immunohistochemistry using an
antibody to the vascular endothelium marker PECAM-1
(CD31) revealed that there were no major defects in the gross
morphology of the hearts of Sox182/2 embryos (Fig. 3). In
addition, the dorsal aortae, intersomitic vessels, and vessels of
the limb bud mesenchyme appeared grossly normal (Fig. 3).
There did not appear to be any hemorrhage or edema in these
embryos at 9.5 dpc. Likewise, at 14.5 dpc, no gross abnormal-
ities, hemorrhage, or edema was detected in Sox182/2 embryos
(Fig. 4). Furthermore, vibrissa follicles in Sox182/2 embryos
had developed in numbers comparable to those in littermates
at the appropriate stage (Fig. 4).
Growth rate of Sox182/2 mice. As a general index of the
well-being of Sox182/2 mice, and to try to detect any subtle
difference in the physiologies of these mice, their growth rate
relative to that of littermate controls was measured in terms of
total weight. This analysis was performed using male litter-
mates from both targeted lines. Over a 2-month period, no
statistically significant difference was observed between
Sox182/2 mice and Sox181/2 and Sox181/1 littermate controls
at any stage (data not shown).
Coat color of Sox182/2 mice. Segregation of alleles of coat
color genes among the stock of Sox182/2 mice was observed
due to the mixed genetic background of CD1 and 129/Sv. This
facilitated the analysis of coat formation, with numerous pig-
mentation phenotypes, including albino, chinchilla, and agouti,
appearing in the stock of Sox182/2 mice. Sox182/2 mice had a
slightly darker appearance than littermate controls on agouti
(Fig. 5) and chinchilla (data not shown) backgrounds. Other-
wise, no visible difference was detected in the coats of
Sox182/2 mice. Microscopic examination of the various hair
types was conducted to further analyze the basis of the differ-
ent coat pigmentation of Sox182/2 mice. Again, this was done
using mice with an agouti phenotype to facilitate examination
of the subapical pheomelanin band typical of many agouti
hairs. Examples of the four main types of pelage hairs—the
FIG. 2. RT-PCR analysis of transcripts from the Sox182/2 and wild-type loci.
At 9.5 dpc, littermates were used to provide RNA samples. Shown are results of
RT-PCR of a region 59 to the HMG box domain expected to be in both the
wild-type and mutant transcripts (labeled 59), RT-PCR of a portion of the lacZ
reporter, expected to be present only in mutant transcripts (labeled LacZ), and
RT-PCR spanning the HMG box region and 186-bp intron (labeled HMG Box).
This also served as a control for genomic DNA contamination. Genomic bands
would be 453 bp in this reaction. Also shown are results of RT-PCR of a portion
of the neor marker, expected to be present only in mutant transcripts (labeled
neo) and RT-PCR of a region of the trans-activation domain (labeled 39).
FIG. 3. Analysis of vascular development in Sox182/2 embryos at 9.5 dpc. (a
and b) PECAM-1 (CD31) immunostaining of Sox181/1 and Sox182/2 embryos,
respectively, showing staining of the aortic arches (aa), atrial chamber (ac),
dorsal aorta (da), outflow tract (oft), and ventricular chamber (vc). (c and d)
Embryos shown in panels a and b, respectively, showing staining of the inter-
somitic vessels (isv) and the vasculature of the limb bud mesenchyme (lbm).












guard hairs, awls, auchenes, and zigzags—appeared morpho-
logically normal, though there was a difference in the pigmen-
tation of many hair types between Sox182/2 mice and litter-
mate controls (Fig. 6). Guard hairs, which never have a
subapical pheomelanin band, appeared the same in Sox182/2
mice and controls upon microscopic examination (Fig. 6).
Some awls from wild-type mice showed a subapical pheomela-
nin band, though most, like all those from Sox182/2 mice, did
not. Many auchenes and zigzags from Sox182/2 mice showed
either a reduced or completely absent pheomelanin band.
Hair formation in Sox182/2 mice. As some hair types are
malformed and underrepresented in Ra mice, namely the lat-
er-forming auchenes and zigzag hairs, we conducted a survey
of the proportion of pelage hair types amongst Sox182/2 mice.
From Fig. 7 it can be inferred that the proportion of guard
hairs and awls was not significantly different between Sox182/2
and littermate controls. There was a marked difference, how-
ever, in the proportion of zigzag hairs, which represented 56%
FIG. 4. Gross morphology and vibrissa formation in Sox182/2 embryos. (a
and b) Gross morphology of Sox181/1 and Sox182/2 embryos, respectively, at
14.5 dpc. (c and d) Close-up view of the embryos in panels a and b, respectively,
showing the grossly visible vibrissa follicle (vf) formation.
FIG. 5. Coat color of Sox182/2 mice. The mice shown in panels a and b are
the same two male agouti littermates. (a) Sox181/1 and Sox182/2 littermates at
8 days after birth. Note the darker color of the Sox182/2 sibling. (b) Sox181/1
and Sox182/2 littermates at 2 months after birth; the color difference is less
pronounced than at 8 days. (c and d) Vibrissae of the Sox181/1 and Sox182/2
littermates, respectively, at 3 months after birth, showing no obvious differences.
FIG. 6. Pigmentation of hair types in Sox182/2 mice. The hair samples shown
are from agouti littermates. (a and b) Subapical pheomelanin banding in
auchenes from Sox181/1 and Sox182/2 mice, respectively. Arrows indicate
pheomelanin bands. The arrowhead indicates a greatly reduced pheomelanin
band. Bars, 200 mm. (c and d) Subapical pheomelanin banding in zigzags from
Sox181/1 and Sox182/2 mice, respectively. The arrow indicates a pheomelanin
band. The arrowhead indicates a greatly reduced pheomelanin band. Note the
absence of any pheomelanin in the zigzag on the right in panel d. Bars, 100 mm.
(e and f) Awls from Sox181/1 and Sox182/2 mice, respectively. Note the pres-
ence of a subapical pheomelanin band in an awl from a Sox181/1 mouse (indi-
cated by an arrow) but not in an awl from a Sox182/2 mouse. Bars, 1 mm.












of total hairs in wild-type mice and 36% in Sox182/2 mice. It is
worth noting that vibrissae and vibrissa follicles seemed normal
at all stages in Sox182/2 embryos and mice (Fig. 4 and 5).
DISCUSSION
The inactivation of Sox18 by gene targeting has demon-
strated that this gene is not vital for embryogenesis. The mild
phenotype observed in Sox182/2 mice is in stark contrast to
that resulting from the Ra mutations. Given the surprisingly
mild effect of the mutation on the phenotype of the Sox182/2
mice, it was important to show that the targeted mutation was
indeed a null mutation by genomic Southern blot. This analysis
confirmed that the targeting event had removed the portion of
the gene encoding the HMG box domain and replaced it with
a lacZ reporter and a neor cassette. It remains formally possi-
ble that the residual, expressed, C-terminal region of SOX18,
containing the trans-activation domain, may retain some func-
tion, perhaps by interaction with another protein in a manner
that does not depend on DNA binding. However, given the
known importance of HMG domain-mediated DNA binding
for the function of other SOX transcription factors, such as
SRY and SOX9, it is reasonable to assume that removal of the
HMG box destroys the function of the SOX18 protein.
Despite the expression pattern of Sox18 during embryogen-
esis and the finding that Sox18 mutations in Ra mice have a
profound effect on cardiovascular and hair follicle develop-
ment (29), Sox18 does not appear to be essential for develop-
ment of these tissues. That the weight of Sox182/2 mice is
similar to that of littermates is also in contrast to the situation
with Ra mice. Shortly after birth, Ra mice are heavier than
normal because of a buildup of fluid due to edema and hem-
orrhage, which soon dissipates. More significantly, however,
they grow more slowly than their littermates (5). The normal
growth rate of Sox182/2 mice indicates that the physiology of
these mice under normal conditions is not unduly affected by
the targeted mutation.
In the light of the contrasting phenotypes of Ra and Sox182/2
mice, it appears that the mutant SOX18 proteins in Ra mice are
acting in a trans-dominant negative manner. It is tempting to
speculate that the mutant SOX18 in Ra mice interferes with
another SOX protein(s), which in the presence of the targeted
null mutation manages to almost fully compensate for the ab-
sence of a fully functional SOX18. One can readily envisage a
situation whereby the mutant SOX18 protein from Ra mice,
which have an intact HMG box but have lost the ability to trans-
activate, competes with wild-type SOX18 (and any other SOX
protein present with a similar target binding site) and prevents the
activation of transcription of the target gene. This hypothesis is
supported by the evidence that SOX proteins display affinity for
similar binding sites (39) and that, at least in some tissue types,
Sox18 is coexpressed with Sox7 and Sox17 (see below). Con-
versely, it is possible that the mutant SOX18 proteins from Ra
mice have gain-of-function mutations and that they interfere with
some other aspects of the cell’s transcription machinery. Analysis
of the phenotype of compound heterozygotes from a cross of
Ra/1 and Sox182/2 mice would be informative with regard to the
mode of action of these mutant proteins and might shed some
light on the nature of SOX proteins. These experiments are in
progress.
Like Ra mice, Sox182/2 mice are most affected in the later-
forming hair types, with a reduction in the number of zigzags.
Also like Ra mice, Sox182/2 mice are darker than their litter-
mates, reflecting a reduction in pheomelanin pigment. Inter-
estingly, another Sox gene, Sox10, has been implicated in pig-
mentation. Sox10 is expressed in neural crest cells as they
migrate to numerous sites in the developing embryo (21), and
mutations in Sox10 result in, apart from other things, hypop-
igmentation (4, 30, 35). One population of neural crest cells is
the melanoblasts, which migrate through the mesenchymal
layer beneath the ectoderm before populating the dermis and
differentiating to melanocytes. Melanocytes that populate the
hair bulb, adjacent to the dermal papilla, donate melanosomes
to the matrix keratinocytes, giving hair its visible pigmentation.
There is no evidence that migrating neural crest cells, which
express Sox10, also express Sox18. Cells that will give rise to the
dermal papilla, adjacent to the hair bulb, do, however, express
Sox18, at least in a transient manner (29). Perturbation of
Sox18 function in Ra and Sox182/2 mice does not result in the
hypopigmentation of hairs, though it does affect the produc-
tion of pheomelanin in hairs. This may be due to the effect
Sox18 mutations have on the agouti signaling peptide: cells that
express the agouti gene reside in the dermal papillae (26).
These are the same cell types as, or a population of cells in
close proximity to, those that express Sox18 transiently during
hair follicle maturation. It is a distinct possibility that normal
Sox18 function is needed for agouti-expressing cells to fulfill
their role completely. It seems unlikely that the receptor an-
tagonized by the agouti signaling peptide is adversely affected
by Sox18 mutations, since in Ra and Sox182/2 mice eumelanin
is produced by hair follicles, indicating that melanocyte-stim-
ulating hormone a and its receptor are functioning normally.
Binding site selection, analyses of chimeric proteins, and phe-
notype rescue experiments indicate that there is scope for redun-
dancy amongst SOX proteins (18, 39). Other evidence for func-
tional redundancy includes the rescue of phenotypes by related
SOX proteins: mouse SOX2 can rescue the defects in the differ-
entiation of the midline glia caused by a mutation in the Drosoph-
ila gene Dichaete (34). In addition, domains of different SOX
proteins may be interchanged with little change in function of the
chimeric protein; chimeric SOX1-SOX9 proteins displayed the
ability to activate transcription after binding the appropriate tar-
get sequences (d-crystallin enhancer, DC5, for SOX1 and Col2a1,
enhancer, COL2C2, for SOX9), demonstrating that the HMG
box domains are interchangeable (17). Further, functional redun-
dancy has been documented amongst other developmentally ex-
FIG. 7. Summary of the prevalence of hair types in Sox182/2 mice. Note the
reduced proportion of zigzag hairs among the coats of Sox182/2 mice. Error bars
represent standard deviations.












pressed gene families, such as the MyoD family (31) and Hox
family (23). There is some overlap in the expression of Sox7-, -17,
and -18 in the developing vascular endothelium (Jane Olsson,
personal communication), and it therefore remains a distinct pos-
sibility given the mild phenotype of Sox182/2 mice that there is
functional redundancy amongst SOX proteins. To address the
question of redundancy amongst these proteins, particularly sub-
group F SOX proteins, the relevant knockout mice, once avail-
able, can be used to generate double and triple knockouts to test
the hypothesis of functional redundancy.
Gene targeting in the mouse and identification of human
mutations have revealed vital roles for SOX genes, with, in the
cases of SOX9 and SOX10, both copies of the gene needed for
normal development. This study provides the first evidence of
a SOX gene that is largely dispensable for embryonic develop-
ment. This study should contribute towards the understanding
of possible interactions of SOX proteins in various embryonic
tissues and the identification of downstream target genes.
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